Lidan Sun

550 total citations
35 papers, 446 citations indexed

About

Lidan Sun is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Lidan Sun has authored 35 papers receiving a total of 446 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Endocrinology, Diabetes and Metabolism, 16 papers in Surgery and 15 papers in Molecular Biology. Recurrent topics in Lidan Sun's work include Diabetes Treatment and Management (25 papers), Pancreatic function and diabetes (16 papers) and Neuropeptides and Animal Physiology (14 papers). Lidan Sun is often cited by papers focused on Diabetes Treatment and Management (25 papers), Pancreatic function and diabetes (16 papers) and Neuropeptides and Animal Physiology (14 papers). Lidan Sun collaborates with scholars based in China, United States and Israel. Lidan Sun's co-authors include Jing Han, Hai Qian, Wenlong Huang, Zheng Li, Xun Huang, Yingying Chu, Yuxuan Dai, Xingguang Cai, Xiaoyun Zhu and Dandan Huang and has published in prestigious journals such as Journal of Medicinal Chemistry, British Journal of Pharmacology and Biochemical Pharmacology.

In The Last Decade

Lidan Sun

33 papers receiving 440 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lidan Sun China 12 219 217 134 93 57 35 446
David C. Hornigold United Kingdom 13 266 1.2× 248 1.1× 202 1.5× 72 0.8× 16 0.3× 30 580
Cécile Galanth France 9 360 1.6× 32 0.1× 111 0.8× 118 1.3× 272 4.8× 10 577
Yuko Murakami Japan 11 109 0.5× 82 0.4× 141 1.1× 50 0.5× 2 0.0× 24 436
Frédéric Mathot Belgium 7 151 0.7× 43 0.2× 104 0.8× 36 0.4× 3 0.1× 8 347
Mitsuru Aono Japan 12 187 0.9× 24 0.1× 80 0.6× 99 1.1× 9 0.2× 36 401
D.A. Nelson United States 13 378 1.7× 23 0.1× 72 0.5× 30 0.3× 9 0.2× 20 583
Emmanuel Y. Dotsey United States 8 95 0.4× 34 0.2× 36 0.3× 26 0.3× 6 0.1× 8 265
Dimitri Sarantakis United States 10 197 0.9× 38 0.2× 21 0.2× 51 0.5× 21 0.4× 16 341
Michael Vicchiarelli United States 10 121 0.6× 57 0.3× 25 0.2× 22 0.2× 3 0.1× 17 349

Countries citing papers authored by Lidan Sun

Since Specialization
Citations

This map shows the geographic impact of Lidan Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lidan Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lidan Sun more than expected).

Fields of papers citing papers by Lidan Sun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lidan Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lidan Sun. The network helps show where Lidan Sun may publish in the future.

Co-authorship network of co-authors of Lidan Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Lidan Sun. A scholar is included among the top collaborators of Lidan Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lidan Sun. Lidan Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gong, Binbin, et al.. (2025). Glucose-dependent insulinotropic peptide and beyond: co-agonist innovations in the treatment of metabolic diseases. European Journal of Pharmacology. 999. 177681–177681. 1 indexed citations
2.
Zhao, Cong, Ling Zhao, Yang Liu, et al.. (2025). The impact of serum uric acid on biological aging and mortality risk: insights from the NHANES and CHARLS cohorts. Frontiers in Nutrition. 12. 1569798–1569798. 1 indexed citations
3.
Sun, Lidan, et al.. (2024). Discovery of novel glucagon-like peptide 1/cholecystokinin 1 receptor dual agonists. European Journal of Pharmaceutical Sciences. 199. 106818–106818. 2 indexed citations
4.
5.
6.
Gong, Binbin, et al.. (2024). Glucagon-like peptide-1 analogs: Miracle drugs are blooming?. European Journal of Medicinal Chemistry. 269. 116342–116342. 14 indexed citations
7.
Han, Jing, et al.. (2023). Novel GLP-1(28–36) amide-derived hybrid peptide A3 with weight loss and hypoglycemic activities. European Journal of Pharmacology. 961. 176200–176200. 2 indexed citations
8.
Zhang, Jinsong, Jianghua Yang, Qianlin Li, et al.. (2023). T Cell Activating Thermostable Self‐Assembly Nanoscaffold Tailored for Cellular Immunity Antigen Delivery. Advanced Science. 10(26). e2303049–e2303049. 10 indexed citations
9.
He, Xinyu, Lizhen Ye, Lidan Sun, et al.. (2023). Determinants of depression, problem behavior, and cognitive level of adolescents in China: Findings from a national, population-based cross-sectional study. Frontiers in Psychiatry. 14. 1159739–1159739. 7 indexed citations
10.
Zhang, Xiaolong, Y. Cai, Heng Chi, et al.. (2023). Discovery of novel OXM-based glucagon-like peptide 1 (GLP-1)/glucagon receptor dual agonists. Peptides. 161. 170948–170948. 3 indexed citations
11.
Chen, Wang, Lidan Sun, Qiang Zhou, et al.. (2023). Emerging roles of oxyntomodulin-based glucagon-like peptide-1/glucagon co-agonist analogs in diabetes and obesity. Peptides. 162. 170955–170955. 10 indexed citations
12.
Li, Jiabin, Binghan Wang, Xinyu He, et al.. (2023). Epidemiological characteristics of norovirus infection in pediatric patients during the COVID‐19 pandemic. Journal of Medical Virology. 95(6). e28874–e28874. 2 indexed citations
13.
Chen, Wang, et al.. (2023). Evolution of peptide YY analogs for the management of type 2 diabetes and obesity. Bioorganic Chemistry. 140. 106808–106808. 13 indexed citations
14.
Yang, Qimeng, Weizhong Tang, Lidan Sun, et al.. (2022). Design of Xenopus GLP-1-Based Long-Acting Dual GLP-1/Y2 Receptor Agonists. Journal of Medicinal Chemistry. 65(20). 14201–14220. 12 indexed citations
15.
Sun, Lidan, et al.. (2019). Novel mono-lipidated dimeric glucagon-like peptide-1 receptor agonist with improved long-acting and hypoglycemic activity. RSC Advances. 9(17). 9654–9662. 6 indexed citations
16.
Sun, Lidan, Xun Huang, Jing Han, et al.. (2016). Site-specific fatty chain-modified exenatide analogs with balanced glucoregulatory activity and prolonged in vivo activity. Biochemical Pharmacology. 110-111. 80–91. 20 indexed citations
17.
Sun, Lidan, Chuandong Wang, Yuxuan Dai, et al.. (2015). Coumaglutide, a novel long-acting GLP-1 analog, inhibits β-cell apoptosis in vitro and invokes sustained glycemic control in vivo. European Journal of Pharmacology. 767. 211–219. 14 indexed citations
18.
Han, Jing, Lidan Sun, Hai Qian, & Wenlong Huang. (2014). Biological activity studies of the novel glucagon-like peptide-1 derivative HJ07. Chinese Journal of Natural Medicines. 12(8). 613–618. 2 indexed citations
19.
Han, Jing, Xun Huang, Lidan Sun, et al.. (2013). Novel fatty chain-modified glucagon-like peptide-1 conjugates with enhanced stability and prolonged in vivo activity. Biochemical Pharmacology. 86(2). 297–308. 43 indexed citations
20.
Chen, Wei, Baowei Yang, Huimin Zhou, et al.. (2011). Structure–activity relationships of a snake cathelicidin-related peptide, BF-15. Peptides. 32(12). 2497–2503. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David C. Hornigold Breakdown of academic impact, for papers by Cécile Galanth Breakdown of academic impact, for papers by Yuko Murakami Breakdown of academic impact, for papers by Frédéric Mathot Breakdown of academic impact, for papers by Mitsuru Aono Breakdown of academic impact, for papers by D.A. Nelson Breakdown of academic impact, for papers by Emmanuel Y. Dotsey Breakdown of academic impact, for papers by Dimitri Sarantakis Breakdown of academic impact, for papers by Michael Vicchiarelli
Rankless by CCL
2026